1. INTRODUCTION
1.1. Market Definition
1.2. Market Segmentation
2. RESEARCH METHODOLOGY
2.1. Research Data
2.2. Assumptions
3. EXECUTIVE SUMMARY
3.1. Research Highlights
4. MARKET DYNAMICS
4.1. Market Drivers
4.2. Market Restraints
4.3. Porters Five Forces Analysis
4.3.1. Bargaining Power of Suppliers
4.3.2. Bargaining Powers of Buyers
4.3.3. Threat of Substitutes
4.3.4. The threat of New Entrants
4.3.5. Competitive Rivalry in Industry
4.4. Industry Value Chain Analysis
5. ASIA PACIFIC NUCLEAR MEDICINE MARKET BY TECHNOLOGY
5.1. PET
5.2. SPECT
6. ASIA PACIFIC NUCLEAR MEDICINE MARKET BY APPLICATION
6.1. Central Nervous System
6.2. Endocrine
6.3. Skeletal
6.4. Gastrointestinal
6.5. Genitourinary
6.6. Pulmonary
7. ASIA PACIFIC NUCLEAR MEDICINE MARKET BY END-USER
7.1. Hospitals
7.2. Diagnostic Centres
7.3. Research Institutions
8. ASIA PACIFIC NUCLEAR MEDICINE MARKET BY COUNTRY
8.1. India
8.2. China
8.3. Japan
8.4. Thailand
8.5. Indonesia
8.6. Taiwan
8.7. Others
9. COMPETITIVE ENVIRONMENT AND ANALYSIS
13.1. Major Players and Strategy Analysis
13.2. Emerging Players and Market Lucrative
13.3. Mergers, Acquisition, Agreements, and Collaborations
13.4. Vendor Competitiveness Matrix
10. COMPANY PROFILES
10.1. Bracco Diagnostic Inc.
10.2. Koninklijke Philips N.V
10.3. Curium
10.4. Lantheus Medical Imaging, Inc.
10.5. Mitsubishi
10.6. Sterigenics International
10.7. GE Healthcare
10.8. FUJIFILM Holdings Corporation
10.9. Cardinal Health
10.10. SC Health Corp